Background Juvenile dermatomyositis (JDM) is a rare idiopathic inflammatory childhood
myopathy of uncertain aetiology. The demographic and clinical presentation of JDM may …

Objective The Pediatric Rheumatology International Trials Organisation (PRINTO) recently
published criteria for classification of patients with juvenile dermatomyositis (DM) as having …

Objective To validate a core set of outcome measures for the evaluation of response to
treatment in patients with juvenile dermatomyositis (DM). Methods In 2001, a preliminary …

Background To evaluate the impact of the duration of chronic inflammation on gene
expression in skeletal muscle biopsies (MBx) from untreated children with juvenile …

Objectives To develop data-driven criteria for clinically inactive disease on and off therapy
for juvenile dermatomyositis (JDM). Methods The Paediatric Rheumatology International …

Abstract Objective The Cutaneous Assessment Tool (CAT) is a comprehensive,
semiquantitative tool for the assessment of skin disease in juvenile dermatomyositis (DM) …

OBJECTIVE: To examine the validity of the Childhood Health Assessment Questionnaire
(CHAQ) in patients with juvenile idiopathic inflammatory myopathy (IIM). METHODS: One …

Objective To develop, validate, and determine the measurement characteristics of a
quantitative tool for assessing the severity of muscle involvement in children with idiopathic …

Objective. There are a number of different approaches to the initial treatment of juvenile
dermatomyositis (JDM). We assessed the therapeutic approaches of North American …

Juvenile dermatomyositis is a chronic inflammatory illness of unknown etiology that affects
primarily muscle and skin. It has an incidence of 2–3 per 1,000,000, per year. The disease …